通过早期喂养诱导耐受以预防湿疹婴儿食物过敏(TEFFA):一项随机对照试验的原理、研究设计与方法
TEFFA为随机、安慰剂对照、双盲、单中心临床试验,计划纳入150名4-8月龄特应性湿疹婴儿,按2:1随机分入主动组(含鸡蛋、牛奶、花生、榛子的磨牙饼干粉,每种食物蛋白初始约2 mg)或安慰剂组,干预6-8个月,主要终点为干预后IgE介导的食物过敏。
要点
- 湿疹婴儿早期引入鸡蛋、牛奶、花生、榛子可能降低食物过敏风险。
- 主动组每种食物蛋白初始约2 mg,每6周增加一次,共增加三次。
- 主要终点为干预6-8个月后对至少一种四种食物的IgE介导食物过敏。
核心结论
- 本试验将评估在特应性湿疹儿童饮食中早期引入致敏食物能否预防食物过敏的发生。
- 该试验将有助于更新食物过敏预防指南。
研究设计与样本
- 随机、安慰剂对照、双盲、单中心临床试验方案。
- 纳入150名4-8月龄特应性湿疹婴儿,按2:1随机分入主动组或安慰剂组。
- 主动组接受含鸡蛋、牛奶、花生、榛子的磨牙饼干粉(每种食物蛋白初始约2 mg),安慰剂组接受不含这四种食物的相同饼干粉,每日一次,干预6-8个月。
- 干预期间研究产品中过敏原含量每6周增加一次,共增加三次。
- 干预结束时对鸡蛋、牛奶、花生或榛子致敏的受试者在后续访视中接受相应食物的口服食物激发试验。
主要发现
- 主要终点为干预6-8个月后(约1岁时)对至少一种四种食物(鸡蛋、牛奶、花生或榛子)的IgE介导食物过敏。
- 次要终点包括多种食物过敏、湿疹严重程度、喘息及针对食物过敏原的致敏水平。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Up to 8% of all children in industrialized countries suffer from food allergies, whereas children with atopic eczema are affected considerably more frequently. In addition, the type and starting time of weaning foods seem to influence the development of food allergies. However, data from interventional studies on weaning are controversial. The aim of this randomized-controlled clinical trial is to investigate, whether an early introduction of hen's egg (HE), cow's milk (CM), peanut (PN), and hazelnut (HN) in children with atopic eczema can reduce the risk for developing food allergies in the first year of life. METHODS: This is a protocol for a randomized, placebo controlled, double blind, single-center clinical trial. One hundred fifty infants with atopic eczema at 4-8 months of age will be randomized in a 2:1 manner into an active group that will receive rusk-like biscuit powder with HE, CM, PN, and HN (initially approximately 2 mg of each food protein) for 6-8 months or a placebo group, whose participants will receive the same rusk-like biscuit powder without HE, CM, PN, and HN on a daily basis. During the interventional period, the amount of allergens in the study product will be increased three times, each after 6 weeks. All study participants who are sensitized to HE, CM, PN, or HN at the end of the interventional period will undergo an oral food challenge to the respective food in a further visit. Primary endpoint is IgE-mediated food allergy to at least one of the four foods (HE, CM, PN or HN) after 6-8 months of intervention (i.e., at around 1 year of age). Secondary endpoints include multiple food allergies, severity of eczema, wheezing, and sensitization levels against food allergens. DISCUSSION: This clinical trial will assess whether an early introduction of allergenic foods into the diet of children with atopic eczema can prevent the development of food allergies. This trial will contribute to update food allergy prevention guidelines. TRIAL REGISTRATION: German Clinical Trials Register DRKS00016770 . Registered on 09 January 2020.
引用
- Kalb B, Meixner L, Trendelenburg V, et al. Tolerance induction through early feeding to prevent food allergy in infants with eczema (TEFFA): rationale, study design, and methods of a randomized controlled trial. Trials. 2022. PMID: 35279213. doi:10.1186/s13063-022-06126-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。